{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T11:44:44Z","timestamp":1773920684281,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2011,11,10]],"date-time":"2011-11-10T00:00:00Z","timestamp":1320883200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s11046-011-9499-2","type":"journal-article","created":{"date-parts":[[2011,11,9]],"date-time":"2011-11-09T09:43:45Z","timestamp":1320831825000},"page":"445-449","source":"Crossref","is-referenced-by-count":11,"title":["Voriconazole, Combined with Amphotericin B, in the Treatment for Pulmonary Cryptococcosis Caused by C. neoformans (Serotype A) in Mice with Severe Combined Immunodeficiency (SCID)"],"prefix":"10.1007","volume":"173","author":[{"given":"Eriques Gon\u00e7alves","family":"Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudete Rodrigues","family":"Paula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"de Assis Baroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walderez","family":"Gambale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,10]]},"reference":[{"key":"9499_CR1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1590\/S0036-46652006000200003","volume":"48","author":"FA Baroni","year":"2006","unstructured":"Baroni FA, Paula C, Silva E, Viani FC, Rivera IN, Oliverira MT, Gambale W. Cryptococcus neoformans strains isolated from church towers in Rio de Janeiro City, RJ, Brazil. Rev Inst Med Trop Sao Paulo. 2006;48:71\u20135.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"9499_CR2","doi-asserted-by":"crossref","unstructured":"Casadevall A, Perfect JR. Cryptococcus neoformans. Washington, DC: American Society for Microbiology;1998.","DOI":"10.1128\/9781555818241"},{"key":"9499_CR3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1099\/jmm.0.46206-0","volume":"55","author":"E Silva","year":"2006","unstructured":"Silva E, Baroni FA, Viani F, Ruiz LS, Gandra RF, Auler ME, Dias AL, Gambale W, Paula CR. Virulence profile of strains of Cryptococcus neoformans var. grubii evaluated by experimental infection in BALB\/c mice and correlation with exoenzyme activity. J Med Microbiol. 2006;55:139\u201342.","journal-title":"J Med Microbiol"},{"key":"9499_CR4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/02681219680000561","volume":"34","author":"K Clemons","year":"1996","unstructured":"Clemons K, Azzi R, Stevens D. Experimental systemic cryptococcosis in SCID mice. J Med Vet Mycol. 1996;34:331\u20135.","journal-title":"J Med Vet Mycol"},{"key":"9499_CR5","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/13693780600810040","volume":"44","author":"J Capilla","year":"2006","unstructured":"Capilla J, Maffei C, Clemons K, Sobel R, Stevens D. Experimental systemic infection with Cryptococcus neoformans var. grubii and Cryptococcus gattii in normal and immunodeficient mice. Med Mycol. 2006;44:601\u201310.","journal-title":"Med Mycol"},{"key":"9499_CR6","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/313757","volume":"30","author":"M Saag","year":"2000","unstructured":"Saag M, Graybill R, Larsen R, Pappas PG, Perfect JR, Powderly WG, Sobel JD, Dismukes WE. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis. 2000;30:710\u20138.","journal-title":"Clin Infect Dis"},{"key":"9499_CR7","first-page":"119","volume":"23","author":"G Deray","year":"2002","unstructured":"Deray G, Mercadal L, Bagnis C. Nephrotoxicity of amphotericin B. Nephrologie. 2002;23:119\u201322.","journal-title":"Nephrologie"},{"key":"9499_CR8","first-page":"481","volume":"13","author":"C Bagnis","year":"2002","unstructured":"Bagnis C, Deray G. Amphotericin B nephrotoxicity. Saudi J Kidney Dis Transpl. 2002;13:481\u201391.","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"4","key":"9499_CR9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s11908-000-0015-y","volume":"2","author":"W Powderly","year":"2000","unstructured":"Powderly W. Cryptococcal meningitis in HIV-infected patients. Curr Infect Dis Rep. 2000;2(4):352\u20137.","journal-title":"Curr Infect Dis Rep"},{"key":"9499_CR10","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1128\/AAC.45.11.3065-3069.2001","volume":"45","author":"M Brandt","year":"2001","unstructured":"Brandt M, Pfaller M, Hajjeh R, Hamill RJ, Pappas PG, Reingold AL, Rimland D, Warnock DW, Cryptococcal Disease Active Surveillance Group. Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998. Antimicrob Agents Chemother. 2001;45:3065\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"9499_CR11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/tcrm.2006.2.2.129","volume":"2","author":"J Pem\u00e1n","year":"2006","unstructured":"Pem\u00e1n J, Salavert M, Cant\u00f3n E, Jarque I, Rom\u00e1 E, Zaragoza R, Viudes A, Gobernado M. Voriconazole in the management of nosocomial invasive fungal infections. Ther Clin Risk Manag. 2006;2:129\u201358.","journal-title":"Ther Clin Risk Manag"},{"key":"9499_CR12","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1128\/AAC.00163-06","volume":"50","author":"F Sabatelli","year":"2006","unstructured":"Sabatelli F, Patel R, Mann P, Mendrick CA, Norris CC, Hare R, Loebenberg D, Black TA, McNicholas PM. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Antimicrob Agents Chemother. 2006;50:2009\u201315.","journal-title":"Antimicrob Agents Chemother"},{"key":"9499_CR13","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1128\/AAC.44.9.2435-2441.2000","volume":"44","author":"F Barchiesi","year":"2000","unstructured":"Barchiesi F, Schimizzi A, Caselli F, Novelli A, Fallani S, Giannini D, Arzeni D, Di Cesare S, Di Francesco LF, Fortuna M, Giacometti A, Carle F, Mazzei T, Scalise G. Interactions between triazoles and amphotericin B against Cryptococcus neoformans. Antimicrob Agents Chemother. 2000;44:2435\u201341.","journal-title":"Antimicrob Agents Chemother"},{"key":"9499_CR14","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1093\/jac\/dki131","volume":"55","author":"C Serena","year":"2005","unstructured":"Serena C, Marin\u00e9 M, Pastor F, Nolard N, Guarro J. In vitro interaction of micafungin with conventional and new antifungals against clinical isolates of Trichosporon, Sporobolomyces and Rhodotorula. J Antimicrob Chemother. 2005;55:1020\u20133.","journal-title":"J Antimicrob Chemother"},{"key":"9499_CR15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11046-006-0039-4","volume":"162","author":"N Mavrogiorgos","year":"2006","unstructured":"Mavrogiorgos N, Zaragoza O, Casadevall A, Nosanchuk J. Efficacy of voriconazole in experimental Cryptococcus neoformans infection. Mycopathologia. 2006;162:111\u20134.","journal-title":"Mycopathologia"},{"key":"9499_CR16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/jac\/dkh361","volume":"54","author":"B Sar","year":"2004","unstructured":"Sar B, Monchy D, Vann M, Keo C, Sarthou JL, Buisson Y. Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002. J Antimicrob Chemother. 2004;54:563\u20135.","journal-title":"J Antimicrob Chemother"},{"key":"9499_CR17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/jac\/dkm123","volume":"60","author":"C Serena","year":"2007","unstructured":"Serena C, Pastor F, Marin\u00e9 M, Rodr\u00edguez M, Guarro J. Efficacy of voriconazole in a murine model of cryptococcal central nervous system infection. J Antimicrob Chemother. 2007;60:162\u20135.","journal-title":"J Antimicrob Chemother"},{"key":"9499_CR18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11046-010-9375-5","volume":"171","author":"EG Silva","year":"2011","unstructured":"Silva EG, Paula CR, Dias AL, Chang MR, Ruiz LS, Gambale W, Prates RA, Ribeiro MS. Combination efficacy of voriconazole and amphotericin B in the experimental disease in immunodeficient mice caused by fluconazole-resistant Cryptococcus neoformans. Mycopathologia. 2011;171:261\u20136.","journal-title":"Mycopathologia"},{"key":"9499_CR19","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(04)16301-0","volume":"363","author":"AE Brouwer","year":"2004","unstructured":"Brouwer AE, Rajanuwong A, Chierakul W. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Lancet. 2004;363:1764\u20137.","journal-title":"Lancet"},{"key":"9499_CR20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1128\/AAC.50.1.113-120.2006","volume":"50","author":"P Schwarz","year":"2006","unstructured":"Schwarz P, Dromer F, Lortholary O, Dannaoui E. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis. Antimicrob Agents Chemother. 2006;50:113\u201320.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-011-9499-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11046-011-9499-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-011-9499-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T23:45:46Z","timestamp":1559346346000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11046-011-9499-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,10]]},"references-count":20,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["9499"],"URL":"https:\/\/doi.org\/10.1007\/s11046-011-9499-2","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,10]]}}}